These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11095159)

  • 21. Novel concepts of statin therapy for cardiovascular risk reduction in hypertension.
    Varughese GI; Patel JV; Lip GY; Varma C
    Curr Pharm Des; 2006; 12(13):1593-609. PubMed ID: 16729872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric transplantation: preventing thrombosis.
    Robertson JD
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S351-61. PubMed ID: 26149047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of coagulation abnormalities in liver disease.
    Potze W; Porte RJ; Lisman T
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):103-14. PubMed ID: 24970667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virchow's triad revisited: blood constituents.
    Chung I; Lip GY
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):449-54. PubMed ID: 15692259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of thrombogenesis in atrial fibrillation.
    Spence D
    Lancet; 2009 Mar; 373(9668):1006; author reply 1006-7. PubMed ID: 19304011
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of pioglitazone and vildagliptin on coagulation cascade in diabetes mellitus--targeting thrombogenesis.
    Khan S; Khan S; Imran M; Pillai KK; Akhtar M; Najmi AK
    Expert Opin Ther Targets; 2013 Jun; 17(6):627-39. PubMed ID: 23356568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticancer treatment and thrombosis.
    Falanga A; Marchetti M
    Thromb Res; 2012 Mar; 129(3):353-9. PubMed ID: 22119391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ukrainian break-through in the European and world strategy of individual prophylaxis of ischemic stroke in patients with arterial hypertension].
    Tolstopiatov SM
    Lik Sprava; 2010; (5-6):3-21. PubMed ID: 21488364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombosis in cardiovascular medicine: a review of pathophysiology, mechanisms of drug action, and the "alphabet" of established and emerging therapies.
    McCarthy J; Szeto J
    Methodist Debakey Cardiovasc J; 2011; 7(4):2-5. PubMed ID: 22143468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation Defects in the Cirrhotic Patient Undergoing Liver Transplantation.
    Parker A; Karvellas CJ
    Transplantation; 2018 Sep; 102(9):1453-1458. PubMed ID: 29757897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulation abnormalities in the cirrhotic patient.
    Muciño-Bermejo J; Carrillo-Esper R; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2013; 12(5):713-24. PubMed ID: 24018489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient.
    Arshad F; Lisman T; Porte RJ
    Liver Int; 2013 Jul; 33(6):820-7. PubMed ID: 23490221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemostasis in liver transplantation: Pathophysiology, monitoring, and treatment.
    Hartmann M; Szalai C; Saner FH
    World J Gastroenterol; 2016 Jan; 22(4):1541-50. PubMed ID: 26819521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Advances in the Understanding of Thrombosis.
    Satoh K; Satoh T; Yaoita N; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):e159-e165. PubMed ID: 31116608
    [No Abstract]   [Full Text] [Related]  

  • 36. Thrombosis and the hypercoagulable state.
    Ratnoff OD
    Circulation; 1984 Nov; 70(5 Pt 2):III72-76. PubMed ID: 6488506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence against hypercoagulability in coronary artery disease.
    Görög P; Ridler CD; Rees GM; Kovacs IB
    Thromb Res; 1995 Aug; 79(4):377-85. PubMed ID: 7482441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the therapy by renin-angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension.
    Remková A; Kratochvíl'ová H; Durina J
    J Hum Hypertens; 2008 May; 22(5):338-45. PubMed ID: 18305548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men.
    Lip GY; Blann AD
    J Hypertens; 1998 Oct; 16(10):1557-9. PubMed ID: 9814630
    [No Abstract]   [Full Text] [Related]  

  • 40. Target organ damage in hypertension: pathophysiology and implications for drug therapy.
    Nadar SK; Tayebjee MH; Messerli F; Lip GY
    Curr Pharm Des; 2006; 12(13):1581-92. PubMed ID: 16729871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.